CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,784 shares (to pay taxes)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 3,224 shares (to pay taxes)
Page 9 of 44 · 872 filings